4.8 Article

HIV-1 neutralizing antibodies induced by native-like envelope trimers

Journal

SCIENCE
Volume 349, Issue 6244, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aac4223

Keywords

-

Funding

  1. NIH [P01 AI082362, R37 AI036082, R01 AI084817, R01 AI076105, P51OD011106]
  2. NIAID-NIH [HHSN27201100016C]
  3. Scripps CHAVI-ID [UM1 AI100663]
  4. Aids Fonds Netherlands [2011032, 2012041]
  5. Canadian Institutes of Health Research (CIHR) Fellowship
  6. Vidi grant from the Netherlands Organization for Scientific Research (NWO)
  7. Starting Investigator Grant from the European Research Council [ERC-StG-2011-280829-SHEV]
  8. IAVI
  9. USAID
  10. Bill & Melinda Gates Foundation

Ask authors/readers for more resources

A challenge for HIV-1 immunogen design is the difficulty of inducing neutralizing antibodies (NAbs) against neutralization-resistant (tier 2) viruses that dominate human transmissions. We show that a soluble recombinant HIV-1 envelope glycoprotein trimer that adopts a native conformation, BG505 SOSIP.664, induced NAbs potently against the sequence-matched tier 2 virus in rabbits and similar but weaker responses in macaques. The trimer also consistently induced cross-reactive NAbs against more sensitive (tier 1) viruses. Tier 2 NAbs recognized conformational epitopes that differed between animals and in some cases overlapped with those recognized by broadly neutralizing antibodies (bNAbs), whereas tier 1 responses targeted linear V3 epitopes. A second trimer, B41 SOSIP. 664, also induced a strong autologous tier 2 NAb response in rabbits. Thus, native-like trimers represent a promising starting point for the development of HIV-1 vaccines aimed at inducing bNAbs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available